The cost of acquiring an automated drug screening device for workplace or clinical settings is a significant factor for organizations. This investment encompasses not only the initial purchase but also potential maintenance agreements, calibration services, and consumable supplies like test cartridges or reagents. Understanding the total cost of ownership is crucial for budgeting and resource allocation.
Investing in reliable, efficient drug screening equipment contributes to safer workplaces, improved healthcare diagnostics, and more informed decision-making. Factors influencing equipment costs include the device’s features (e.g., number of drugs screened, throughput, automation level), technology employed (e.g., immunoassay, chromatography), and manufacturer. Historically, advancements in technology have led to more compact, user-friendly, and cost-effective devices.